This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sainsbury, A. Articles by Gardiner, E. M. Search for Related Content PubMed PubMed Citation Articles by Sainsbury, A. Articles by Gardiner, E. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2003, p. 5225-5233, Vol. 23, No. 15
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.15.5225-5233.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Synergistic Effects of Y2 and Y4 Receptors on Adiposity and Bone Mass Revealed in Double Knockout Mice

Neurobiology Program,¹ Bone and Mineral Program, Garvan Institute of Medical Research, St Vincent's Hospital,² Faculty of Medicine, University of New South Wales, Sydney, Australia,⁴ Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Chuo-Ku, Kobe, Japan³

Received 6 January 2003/ Returned for modification 2 April 2003/ Accepted 8 May 2003

Neuropeptide Y regulates numerous physiological processes via at least five different Y receptors, but the specific roles of each receptor are still unclear. We previously demonstrated that Y2 receptor knockout results in a lean phenotype, increased cancellous bone volume, and an increase in plasma pancreatic polypeptide (PP), a ligand for Y4 receptors. PP-overexpressing mice are also known to have a lean phenotype. Deletion of the Y4 receptor also produced a lean phenotype and increased plasma PP levels. We therefore hypothesized that part of the Y2 phenotype results from increased PP action on Y4 receptors and tested this in PP transgenic Y4^-/- and Y2^-/- Y4^-/- double knockout mice. Bone mass was not altered in Y4 knockout mice. Surprisingly, despite significant hyperphagia, Y2^-/- Y4^-/- mice retained a markedly lean phenotype, with reduced body weight, white adipose tissue mass, leptinemia, and insulinemia. Furthermore, bone volume was also increased threefold in Y2^-/- Y4^-/- mice, and this was associated with enhanced osteoblastic activity. These changes were more pronounced than those observed in Y2^-/- mice, suggesting synergy between Y2 and Y4 receptor pathways. The lack of bone changes in PP transgenic mice suggests that PP alone is not responsible for the bone mass increases but might play a major role in the lean phenotype. However, a synergistic interaction between Y2 and Y4 pathways seems to regulate bone volume and adiposity and could have important implications for possible interventions in obesity and for anabolic treatment of osteoporotic bone loss.

This article has been cited by other articles:

• Kamiji, M. M., Inui, A. (2007). Neuropeptide Y Receptor Selective Ligands in the Treatment of Obesity. Endocr. Rev. 28: 664-684 [Abstract] [Full Text]  
• Lundberg, P., Allison, S. J., Lee, N. J., Baldock, P. A., Brouard, N., Rost, S., Enriquez, R. F., Sainsbury, A., Lamghari, M., Simmons, P., Eisman, J. A., Gardiner, E. M., Herzog, H. (2007). Greater Bone Formation of Y2 Knockout Mice Is Associated with Increased Osteoprogenitor Numbers and Altered Y1 Receptor Expression. J. Biol. Chem. 282: 19082-19091 [Abstract] [Full Text]  
• Baldock, P. A., Allison, S. J., Lundberg, P., Lee, N. J., Slack, K., Lin, E.-J. D., Enriquez, R. F., McDonald, M. M., Zhang, L., During, M. J., Little, D. G., Eisman, J. A., Gardiner, E. M., Yulyaningsih, E., Lin, S., Sainsbury, A., Herzog, H. (2007). Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy Homeostasis. J. Biol. Chem. 282: 19092-19102 [Abstract] [Full Text]  
• Lin, S., Lin, E.-J. D., Boey, D., Lee, N. J., Slack, K., During, M. J., Sainsbury, A., Herzog, H. (2007). Fasting Inhibits the Growth and Reproductive Axes via Distinct Y2 and Y4 Receptor-Mediated Pathways. Endocrinology 148: 2056-2065 [Abstract] [Full Text]  
• Sainsbury, A., Bergen, H. T., Boey, D., Bamming, D., Cooney, G. J., Lin, S., Couzens, M., Stroth, N., Lee, N. J., Lindner, D., Singewald, N., Karl, T., Duffy, L., Enriquez, R., Slack, K., Sperk, G., Herzog, H. (2006). Y2Y4 Receptor Double Knockout Protects Against Obesity Due to a High-Fat Diet or Y1 Receptor Deficiency in Mice. Diabetes 55: 19-26 [Abstract] [Full Text]  
• Andersson, N., Islander, U., Egecioglu, E., Lof, E., Swanson, C., Moverare-Skrtic, S., Sjogren, K., Lindberg, M. K, Carlsten, H., Ohlsson, C. (2005). Investigation of central versus peripheral effects of estradiol in ovariectomized mice. J Endocrinol 187: 303-309 [Abstract] [Full Text]  
• Ducy, P. (2005). Is Menopause Getting on Your Nerves?. IBMS BoneKEy 2: 11-13 [Full Text]  
• Schwindinger, W. F., Giger, K. E., Betz, K. S., Stauffer, A. M., Sunderlin, E. M., Sim-Selley, L. J., Selley, D. E., Bronson, S. K., Robishaw, J. D. (2004). Mice with Deficiency of G Protein {gamma}3 Are Lean and Have Seizures. Mol. Cell. Biol. 24: 7758-7768 [Abstract] [Full Text]  
• (2004). Genetically Modified Animals in Endocrinology. Endocr. Rev. 25: 512-519 [Full Text]  
• Elefteriou, F., Takeda, S., Ebihara, K., Magre, J., Patano, N., Ae Kim, C., Ogawa, Y., Liu, X., Ware, S. M., Craigen, W. J., Robert, J. J., Vinson, C., Nakao, K., Capeau, J., Karsenty, G. (2004). Serum leptin level is a regulator of bone mass. Proc. Natl. Acad. Sci. USA 101: 3258-3263 [Abstract] [Full Text]